CSF2 and autoimmune disease: However, inhibition of GM-CSF-GM-CSFR signaling was suggested to be useful for the treatment of several inflammatory or autoimmune diseases, and neutralizing antibodies for GM-CSF and antibodies blocking GM-CSFR have been under clinical trial [78].